Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Active Not Recruiting NCT07281937

A Study of Weekly Oral Ecnoglutide (VRB-101) in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

Conditions: Obesity, Overweight

Sex: All

Ages: 18 Years – 80 Years

Healthy volunteers: No

Phase: PHASE2

Enrollment: 206

Sponsor: Verdiva Bio Dev Limited

Location: Clinical Study Site 103 Anniston Alabama

Summary

The aim of this study is to evaluate the efficacy of VRB-101 for body weight reduction compared to placebo in participants who have obesity or overweight with weight-related comorbidities.

Eligibility Criteria

Inclusion Criteria: * Have hemoglobin A1c (HbA1c) \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07281937). StuddyBuddy aggregates publicly available trial information.